A new startup named Uptiv Health launched to make infusion care more accessible and enjoyable for patients. The company, which was built at Redesign Health, is launching its flagship infusion center later this month in the Detroit area.
Allurion Technologies has commercialized a gastric balloon in the form of a pill that patients swallow. But the weight loss platform from the now NYSE-listed company also include AI-driven software that provides insights about a patient’s progress, technology with the potential for use alongside obesity drugs.
Horizon Healthcare Services’ 2.5 million commercial members now have access to Resilience Lab clinicians. The mental health provider matches patients with therapists based on their unique needs and offers in-person care and online care.
A Phase 2b-ready Cyclerion Therapeutics drug candidate for a rare mitochondrial disease gets new life under a new startup led by a familiar face. Starup Tisento Therapeutics acquired the Cyclerion drug and is backed by a Series A round financing.
TG Therapeutics’ multiple sclerosis drug Briumvi will be commercialized in Europe by Neuraxpharm. The Germany-based company paid $140 million up front for certain rights to the drug, which received European Commission approval in June.